文献速递慢性肾脏病

左心室质量指数对慢性肾脏病患者预后的预测价值

Prognostic values of left ventricular mass index in chronic kidney disease patients.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

本研究基于CRIC队列1352例CKD患者,评估左心室质量指数(LVMI)对死亡和新发心衰的预测价值。中位随访7.7年,326例死亡、208例新发心衰。LVMI对死亡的区分能力(Harrell's C指数66%)低于SHARP评分(71%),对心衰的区分能力亦低于CRIC模型。LVMI在SHARP评分和CRIC模型基础上仅增加2-3%的区分能力和3.0-4.8%的风险重分类能力。结论:在CKD中仅用LVMI进行死亡和心衰风险分层未提供明显预后价值。

要点

  • LVMI对CKD患者死亡的区分能力低于SHARP评分。
  • LVMI对心衰的区分能力低于CRIC模型。
  • LVMI在现有模型上仅小幅提升区分和重分类能力。

核心结论

  • 在CKD患者中,仅测量LVMI用于死亡风险分层未显示明显预后价值,对心衰风险分层亦可能如此。

研究设计与样本

  • 研究纳入CRIC队列中1352例CKD患者,采用超声心动图测量LVMI,随访中位7.7年。

主要发现

  • 随访期间326例患者死亡,208例发生新发心衰。
  • LVMI、SHARP评分和CRIC心衰模型均与死亡和心衰风险显著相关(P < 0.001)。
  • LVMI对死亡的Harrell's C指数为66%,低于SHARP评分的71%。
  • LVMI对心衰的Harrell's C指数在测试队列为72%(CRIC模型79%),在验证队列为71%(CRIC模型74%)。
  • LVMI在SHARP评分和CRIC模型基础上仅增加2-3%的区分能力和3.0-4.8%的风险重分类能力。

临床怎么用

  • 在CKD患者中,不建议仅依据LVMI进行死亡和心衰的风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left ventricular hypertrophy is causally implicated in the high risk of death and heart failure (HF) in chronic kidney disease (CKD) patients. Whether the left ventricular mass index (LVMI) adds meaningful predictive power for mortality and de novo HF to simple risk models has not been tested in the CKD population. METHODS: We investigated this problem in 1352 CKD patients enrolled in the Chronic Renal Insufficiency Cohort (CRIC). LVMI was measured by echocardiography and the risks for death and HF were estimated by the Study of Heart and Renal Protection (SHARP) score, a well-validated risk score in CKD patients. RESULTS: During a median follow-up of 7.7 years, 326 patients died and 208 had de novo HF. The LVMI and the SHARP score and a cross-validated model for HF (CRIC model) were all significantly (P < 0.001) related to the risk of death and HF. LVMI showed a discriminatory power for death (Harrell's C index 66%) inferior to that of the SHARP score (71%) and the same was true for the risk of HF both in the test (LVMI 72%, CRIC model 79%) and in the validation cohort (LVMI 71%, CRIC model 74%). LVMI increased very little the discriminatory (2-3%) and the risk reclassification power (3.0-4.8%) by the SHARP score and the CRIC model for HF for the same outcomes. CONCLUSIONS: In CKD, measurement of LVMI solely for the stratification of risk of death and perhaps for the risk of HF does not provide evident prognostic values in this condition.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Tripepi G, D'Arrigo G, Mallamaci F, et al. Prognostic values of left ventricular mass index in chronic kidney disease patients. Nephrol Dial Transplant. 2021. PMID: 31860093. doi:10.1093/ndt/gfz254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。